Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Year
2024
Data d'inici
Data de tancament
Descripció
Postdoctoral researcher
Codi
2024-325
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Project Manager_Medical Molecular Imaging Group_20240324
Codi
2024-324
Reclutant
Actiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Neurologist Specialized In Neuromuscular Disease And Clinical Trials. Peripheral Nervous System Unit_2024321
Codi
2024-321
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Support Technician for the Microscopy Platform_20240322
Codi
2024-322
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Core Facilities Project Manager_20240323
Codi
2024-323
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
International Post-award Research Officer_20240318
Codi
2024-318
Reclutant
Actiu
Year
2024
Data d'inici
Data de tancament
Descripció
International Grants Manager (Post-Award)_20240319
Codi
2024-319
Reclutant
Actiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Neurologist Specialized In Neuromuscular Disease And Clinical Trials. Peripheral Nervous System Unit_20240320
Codi
2024-320
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Health & Safety Specialist_20240317
Codi
2024-317
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
PhD student: An in-vitro human model to study MOGAD physiopathology_20240315
Codi
2024-315
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Innovation Manager_20240316
Codi
2024-316
Reclutant
Inactiu

Prevención de la mortalidad con la administración a largo plazo de albúmina humana en sujetos con cirrosis descompensada y ascitis.

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio de fase 3, aleatorizado y doble ciego para evaluar laeficacia y la seguridad de MK-0616 en comparación con ezetimiba o ácidobempedoico o ezetimiba más ácido bempedoico en adultos con hipercolesterolemia...

  • Protocol code: MK-0616-018
  • EudraCT code: No aplica
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Principal investigator:  Rial Lorenzo , Nuria
  • Research group:  Malalties infeccioses
  • Service: Medicina Interna
  • Phase: Phase III
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio abierto, multicéntrico que evalúa los cambios en la tensiónarterial en participantes con narcolepsia en la transición del oxibato con niveles altos desodio a XYWAV

  • Protocol code: JZP258-406-01
  • EudraCT code: No aplica
  • Pathology: Malalties del sistema respiratori
  • Principal investigator:  Romero Santo-Tomas, Odile
  • Research group:  Pneumologia
  • Service: Neurofisiologia
  • Phase: Phase III
  • Recruiting: Open
  • Status: Tancat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio de fase IIa, aleatorizado, doble ciego y ocntrolado con placebo para evaluar la eficacia y la seguridad de efinopegdutida (MK-6024) en adultos con cirrosis compensada secundaria a esteatohepatitis asociada a disfunción metabólica.

  • Protocol code: MK-6024-017
  • EudraCT code: No aplica
  • Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified
  • Principal investigator:  Pericàs Pulido, Juan Manuel
  • Research group:  Liver Diseases
  • Service: Hepatology
  • Phase: Fase II
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A phase IIb, multicentre, randomised, double-blind, placebo controlled, crossover study to evaluate the efficacy and safety of Dirocaftor/Posenacaftor/Nesolicaftor in subjects with cystic fibrosis aged 18 years or older (CHOICES)

  • Protocol code: HIT-CF-001
  • EudraCT code: _
  • Pathology: Diseases of the respiratory system
  • Principal investigator:  Álvarez Fernandez, Antonio
  • Research group:  Pneumology
  • Service: Pneumologia
  • Phase: Phase II
  • Recruiting: Open
  • Status: Close

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.
Year
2024
Data d'inici
Data de tancament
Descripció
Predoctoral FPI contract_Research group on Neuromuscular and Mitochondrial diseases_20240310
Codi
2024-310
Reclutant
Actiu
Year
2024
Data d'inici
Data de tancament
Descripció
Predoctoral FPI contract_Nanopartículas Farmacocinéticas_20210312
Codi
2024-312
Reclutant
Actiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Scientific Clinical Monitor_Rheumalogy Research Group_20240313
Codi
2024-313
Reclutant
Actiu